Abstract
UCP2 Mitigates the Loss of Human Spermatozoa Motility by Promoting mROS Elimination
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Introduction
Approximate 15% to 20% of couples worldwide have infertility, with males accounting for about 40% to 50% of cases [1] . Male infertility is associated with abnormalities in various aspects, such as semen volume, spermatozoa concentration, spermatozoa motility, and morphology [2] [3] [4] [5] . Poor spermatozoa motility (also called asthenozoospermia) is a major cause of male infertility [4] [5] [6] . Spermatozoa motility, a key indicator of semen quality, is driven by flagellae, which is dependent on an adequate and continuous supply of ATP. Lack of ATP supply [7] , overproduction of reactive oxygen species (ROS) [8] , calcium dyshomeostasis [6] , aging [9] , and certain forms of environmental pollution [10] [11] [12] can lead to impaired spermatozoa motility.
Mitochondria plays critical roles in intracellular ATP production and maintenance of calcium homeostasis. It is also the major source of ROS. Previous studies have revealed the close relationship between morphology and functions of mitochondria and spermatozoa motility [13] [14] [15] . These studies demonstrated that the maintenance of mitochondrial homeostasis is critical for spermatozoa motility and semen quality. When mitochondria are damaged, a major outcome is the overproduction of mitochondrial reactive oxygen species (mROS), which then elevates the level of total cellular ROS. Excessive ROS can cause severe oxidative damages to spermatozoa membranes and DNA [14, 16] , leading to lowered integrity of these subcellular components, impaired spermatozoa motility, and subsequent infertility [8, 16, 17] . Spermatozoa motility is considered the earliest and most sensitive indicator of spermatozoa oxidative damage [17] .
Uncoupling protein 2 (UCP2), a mitochondrial membrane protein, is widely expressed in mammalian tissues. UCP2 plays important roles in a variety of physiological processes, such as food intake [18] , insulin secretion, and immunology [19, 20] . UCP2 is also vital to many pathological conditions [21] . However, the function of UCP2 in male reproduction remains unclear. Recently, a research group found expression of UCP2 in the spermatozoa of zebrafish and yellow catfish and revealed the close relevance between the expression of UCP2 and spermatozoa ROS level, degree of oxidative damage, and post-thaw viability [22, 23] . In human spermatozoa, the transcription of UCP2-encoding gene has been observed by quantifying mRNA,however, the UCP2 protein level was not further measured in the same study [24] . The aims of the present study are to determine the correlation between the expression of UCP2 and human spermatozoa mobility and to elucidate the underlying mechanism for the regulation of spermatozoa motility by UCP2.
Materials and Methods

Spermatozoa preparation
Human semen samples were collected from 200 male fertility evaluation donors between 25 to 35 years old accordingto World Health Organization (WHO) criteria. All participants signed a written informed consent. The study was approved by the Ethics Committee of the hospital and the protocols were carried out in accordance with the approved guidelines. Semen samples were collected by masturbation after a stipulated period of 2-7 days of abstinence. The collected semen samples were analyzed by computeraided spermatozoa analysis (CASA, IVOS, Hamilton, USA) and identifiedas normospermic (NS, n = 120) and asthenospermic (AS, n = 80) according to WHO Guidelines. Spermatozoa were isolated by density gradient centrifugation after liquefaction for 15-30 min at 37 °C. In brief, semen samples (2 mL) were added on top of a colloidal silica suspension (Percoll, Sigma Aldrich, UK) made of 80% and 40% layers (1 mL each), and Immunofluorescence staining Spermatozoa were fixed using 4% paraformaldehyde for 15 min. Spermatozoa membrane was permeated with cold 95% ethyl alcoholfor 15 min. After washing, spermatozoa were blocked for 1h with 1% fetal bovine serum (FBS) in phosphate-buffered saline (PBS). The spermatozoa were incubated with mouse polyclonal anti-UCP2 (1:50, Abcam) for 4h at room temperature, and then withFITC-conjugated anti-mouse (1:5000, Bioword) for 2h atroom temperature. Cells were then rinsed with PBS three times for 5 min each. The negative control was only incubated withsecondary antibody. Images were captured by an Olympus FluoView FV500 microscope.
Western blotting
Semen samples were incubated with 100μl SDS lysis buffer (Beyotime, China) for 30 min and then centrifuged at 12, 000 × g for 10min at 4 °C, and the supernatant was analyzed for protein concentration. Equal amount of protein (40 μg) was separated by 12% SDS-PAGE and transferred to PVDF membrane (Millipore, USA).The membranes were blocked with 5% non-fat milk for 1 hour at room temperature. After that the membranes were then incubated overnight at 4 °C with primaryantibodies of both polyclonal anti-UCP2 (1:500, Abcam, USA) and polyclonal anti-β-actin (1:200, Boster, China) followed by the incubation with HRP-conjugated anti-rabbit IgG secondary antibodies (1:500, Beyotime, China) for 2h at room temperature, and then washed three times with Tris-buffered saline containing 0.1% Tween 20 (TBST). The chemiluminescence signal was captured using Super Signal West Pico (Pierce, USA), and the results were analyzed using Quantity One software (AlphaEaseFc).
Measurement of ATP content
The ATP content of spermatozoa samples was measured using the ATP Detection Kit (Beyotime, China). Spermatozoa samples were lysed by ATP lysis buffer for 30 min, and then centrifuged at 12, 000× g for 10 min at 4 °C. The supernatant (40 μl) after being mixed with 100 μl ATP detection buffer was added into 96-well black plates. The ATP content (nmol/mg) was analyzed using an automatic microplate reader (Biotek, USA).
Measurement of mitochondrial membrane potential
The mitochondrial membrane potential (MMP) was analyzed with a JC-1 kit (Sigma). The spermatozoa samples (1~2× 10 6 /mL) were washed with PBS, and incubated with 1.5 μl JC-1 working solution (2.5mg/ mL) at 37 °C for 30 min. After washing with PBS, the spermatozoa samples were suspended and analyzed by Flow Cytometry (BD, USA). Ten thousand spermatozoa were recorded in each group, and the MMP level was calculated using the ratio of green florescence intensity to red florescence intensity.
Measurement of ROS content in mitochondria
The ROS content in mitochondria (mROS) was measured using MitoSOX™Red (Invitrogen). Spermatozoa were incubated with 10 μM Mitosox at 37 °C for 10 min. Then samples were washed with PBS and analyzed for mROS content using Flow Cytometry. Ten thousand spermatozoa were recorded in each group, and the mean fluorescent intensity (MFI) was measured in a PE channel.
Statistical Analysis
All data wasanalyzed by one-way ANOVA followed by a post-hoc comparison test using either LSD (when equal variances were assumed) or Dunnett's T3 (when equal variances were not assumed) method when more than two groups were compared. The data was presented as the mean ± SEM, with a statistically significant difference defined as P < 0.05. All the statistical procedures were performed using SPSS 18.0.
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Results
Expression of UCP2 in human spermatozoa and its correlation with spermatozoa motility
In human spermatozoa, the transcription of UCP2-encoding gene has been observed by quantifying mRNA level [24] , but no study has been performed to track UCP2 expression at the protein level. In the present study, to determine whether the UCP2 protein is expressed in human spermatozoa, the prepared spermatozoa were subjected to immunofluorescence staining using antibodies against UCP2. The results shown in Fig. 1A strongly suggest that UCP2 is expressed in human spermatozoa and mainly located at the mid-region of spermatozoa. To our knowledge, this is the first time that the UCP2 protein is found to be expressed in human spermatozoa. Moreover, the UCP2 protein levels of both NS and AS groups were quantified and compared by western blotting to investigate the correlation of UCP2 expression and spermatozoa motility. The results show that the UCP2 expression is significantly higher in the NS group than in the AS group (P < 0.05, Fig. 1B ), indicating that UCP2 is likely involved in the regulation of spermatozoa motility.
Effect of the UCP2-specific inhibitor on spermatozoa motility, mROS content, and mitochondrial function
To further understand how UCP2 regulates spermatozoa motility, Genipin (Sigma Chemical Co., St. Louis, MO, USA), a highly selective UCP2 inhibitor, was used to block UCP2 activity. The concentrations of Genipin used in this study are based on a published study [23] . Interestingly, as shown in Fig. 2B , the progressive motility (PR), the total motility (progressive plus nonprogressive motility), and the curvilinear velocity (VCL) of spermatozoa are all remarkably decreased in the presence of Genipin (P < 0.05). A significant increase inthe mROS level is observed after Genipin treatment (P < 0.05, Fig. 2C ). On the other hand, no significant difference is observed for mitochondrial membrane potential (MMP) activity and ATP content between Genipin-treated and nontreated spermatozoa (P>0.05, Fig. 2D and 2E) , although a slight decrease of ATP contentoccurs in spermatozoa treated with 100 μmol/L Genipin (Fig. 2E) . These results indicate that the specific inhibition of UCP2 by Genipin in spermatozoa can down-regulate the motility of spermatozoa, which is probably achieved by either promoting the mROS production or lowering the mROS elimination rather than by blocking the ATP production in human spermatozoa. In addition, the UCP2 protein level in Genipin-treated spermatozoa is slightly reduced compared with the level in nontreated spermatozoa (P < 0.05, Fig. 2A) , which is likely due to the interference of Genipin with the UCP2 translation process. 
Effect of H 2 O 2 treatment on UCP2 expression and spermatozoa motility
Many studies have demonstrated that mROS is a critical factor regulating spermatozoa motility. In addition, it has been confirmed that there is a close correlation between UCP2 expression and cellular oxidative stress. However, the role that UCP2 could play in regulating mROS content in spermatozoa remains unclear. To further understand the relevant mechanism, H 2 O 2 was applied to the spermatozoa for 30 min with the concentrations ranging from 0 to 100 μmol/L [25] . As expected, the mROS content is significantly increased after H 2 O 2 -treatment (P < 0.05, Fig. 3A) . Meanwhile, the total motility, the progressive motility, and VCL are significantly decreased after H 2 O 2 -treatment compared with controls (P < 0.05, Fig. 3B ). Interestingly, the UCP2 level is significantly elevated in spermatozoa treated with 25 μmol/L and 50 μmol/L H 2 O 2 compared with controls (P < 0.05, Fig. 3C ), indicating that, within a certain range, mildly excessive ROS can promote UCP2 expression. Combined with the data obtained in the Genipin-treatment experiments, it is clearly shown that the elevation of UCP2 expression is helpful for the maintenance of mROS content at a normal physiological level and thus mitigates the negative impact of ROS on spermatozoa motility.
Effect of ROS scavenger on UCP2 expression and spermatozoa motility
To illuminate whether ROS scavengers can affect UCP2 expression or spermatozoa motility, N-acetyl-l-cysteine (NAC), a widelyused ROS scavenger, was used in this study. The concentration and duration of NAC treatment were determined in a spermatozoa viability experiment (data not shown). As expected, the level of spermatozoa mROS is reduced after NAC treatment (Fig. 4A ). In addition, as shown in Fig. 4B , a significant increase is observed in the VCL mobility in the treatments with 50 µmol/L and 100 µmolL NAC (P < 0.05). However, there is no significant difference of UCP2 levels between NAC-treated and nontreated (B) UCP2 protein levels was detected by western blot. The optical density values were normalised to β-actin loading control, and means ± SD were graphed (relative expression) to semiquantitatively compare the protein levels. (C). Sperm motility and VCL were analyzed using CASA after treatment with different concentration of NAC. *P < 0.05.
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Cellular Physiology and Biochemistry spermatozoa (P>0.05, Fig. 4C ), indicating that the decrease of mROS level caused by ROS scavenger has no impact on the expression of UCP2. Combined with the data obtained in the experiments involving H 2 O 2 treatment, we conclude that only mildly excessive mROS can induce an elevated UCP2 expression level, while normal physiological level or a lower level of mROS has no impact on the expression of UCP2 in human spermatozoa.
Discussion
Poor spermatozoa motility has been found associated with various factors, such as the over-production of ROS [8] , mitochondrial dysfunction in energy production (i.e. the abnormalities in levels of ATP and MMP) [7, 26] , excessive DNA fragmentation [27] , defective morphology [3] , and so on. In the present study, UCP2 is found to have an intimate relationship with spermatozoa motility. The UCP2 expression levels are significantly higher in the NS group than in the AS group, while the specific inhibition of UCP2 by Genipin results in a significant decrease in spermatozoa total motility, progressive motility, and VCL. These observations raise a question: how does UCP2 regulate human spermatozoa motility?
It is known that UCP2 plays vital roles in maintaining cellular mitochondrial homeostasis via regulating energy balance [28] , maintaining calcium homeostasis, controlling mROS levels [29, 30] , and regulating cellular autophagy and apoptosis [31] . UCP2 can protect cells from oxidative damages via eliminating mROS [30] . Published studies have suggested that a UCP2 homologue, UCP1, regulates ATP production and maintains cellular energy balance in many cell types through uncoupling electron transport and ATP generation [32, 33] . Theoretically, protons pass through the inner mitochondrial membranes and form electrochemical gradientsresulting in the production of ATPs coupled with the production of a large number of mROS [34] . Hence, the content of mROS is positively correlated with the levels of ATP and MMP. A positive correlation between mitochondrial energy function and spermatozoa motility has been demonstrated [14, 26, 35, 36] . In these studies, it was found that the levels of MMP and ATP are significantly higher in the NS group than in the AS group, but the mROS levels show a reverse trend, implying that one special mechanism exists in the NS group to either inhibit mROS production or promote mROS elimination. Interestingly, in the present study, upon the inhibition of UCP2, ATP and MMP levels are found unaffected while the mROS level is observed significantly elevated, indicating that UCP2 may fulfill its function by promoting mROS scavenging rather than by facilitating ATPproduction in human spermatozoa.
To further demonstrate the relationship between UCP2 and the mROS level, H 2 O 2 and NACwere individually applied to increase and decrease the mROS levels, respectively. The H 2 O 2 -treatment induces an elevated measured mROS level coupled with the impaired spermatozoa mobility as expected. Unexpectedly, the moderate level of H 2 O 2 can slightly induce the UCP2 expression although highly excessiveH 2 O 2 shows a negative impact on the UCP2 expression. The NAC treatment facilitates the mROS scavenging, but does not have an impact on the UCP2 expression. Combined with the data obtained in the Genipin-treatment of UCP2, it is suggested that an UCP2-mROS-motility regulatory systemexists in human spermatozoa. In this system, the elevation of UCP2 expressioncan enhance spermatozoa motility by promoting mROS scavenging, while slightly over-produced mROS in turn can serve as a feedback signal forthe induction of UCP2 expression. The resultsobtained in the Genipin-, H 2 O 2 -, and NAC-treatment experiments, combined with the observation of higher level of UCP2 expression in the NS group, suggest that the spermatozoa with high motility are more vigorousin mROS scavenging.
Normal physiologicallevels of ROS play roles in spermatogenesis and maturation [37] , capacitation [38, 39] , acrosome reaction [38] , and the fusion programme of spermatozoa and oocyte [37, 40, 41] . Nevertheless, excessive ROS will induce severe damagestospermatozoa membrane lipids, DNA, andultra-structures, leading to a decreased spermatozoa motility and the subsequent infertility [8, 37, 42] . Several antioxidant enzymes, such as catalase Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPX), were detected in the seminal plasma [43, 44] . However, few intracellular antioxidant mechanisms were discerned in spermatozoa. In this study, the results demonstrate that UCP2 plays a pivotal rolein ROS scavenging in human spermatozoa, and thus affects spermatozoa motility. Recently, a research group observed similar effects of UCP2 expression in the spermatozoa of zebrafish and yellow catfish [22, 23] . It was found that a UCP2 promoter significantly improved the viability of post-thaw spermatozoa, accompanied by the decreased levels of ROS and MDA [23] . The UCP2 expression in the zebrafish spermatozoa can be down-regulated by Genipin [30] consistent with our observation in humanspermatozoa, and furthermore, could be up-regulated by acute cold exposure [30] . It is noteworthy that the spermatozoaare terminally differentiated cells, with DNA tightly compacted in the head, most of organelles removed during spermatozoa maturation, and only a few organelles such as mitochondria retained. In addition, it is believed that the spermatozoa lack transcription and translation systems. Nevertheless, Gur et al. (2006) showed mitochondrial ribosomes are actively involved in protein translation during capacitation of spermatozoa. Moreover, they confirmed that the nuclear-encoded mRNA in spermatozoa could be translated on the spermatozoa mitochondrial ribosomes, and such an ability of translation is related to the spermatozoa viability, motility, capacitation, and acrosome reaction [45] . These studies proved that matured spermatozoa retain the ability of self-regulation, which can explain why the UCP2 expression in human spermatozoa can be regulated by Genipin and H 2 O 2 . These evidences further support the existence of UCP2 regulation system in human spermatozoa.
Conclusion
In summary, in this study, it is the first time to demonstrate the existence of an UCP2-mROS-motility regulatory system in human spermatozoa. UCP2 protein is expressed in human spermatozoa, and regulates spermatozoa motility. UCP2 controls mROS levels by promoting mROS elimination, and mildly over-produced mROS serving as a signal can induce the UCP2 expression. Therefore,the exploitationand regulation of UCP2-mROS system might pose a new strategy to treat patients with poor spermatozoa motility. However, for this purpose, more studies with the aim of revealing the in-depth mechanism of the UCP2-mROS-motility regulatory system and its roles in regulating other functions in spermatozoa are needed.
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